Cargando…
Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. To date, NAFLD is the most frequent chronic liver disease seen day by day in clinical practice across most high-income countries, affecting nearly 25–30% of adults in the general population and u...
Autores principales: | Mantovani, Alessandro, Dalbeni, Andrea, Beatrice, Giorgia, Cappelli, Davide, Gomez-Peralta, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878156/ https://www.ncbi.nlm.nih.gov/pubmed/35207239 http://dx.doi.org/10.3390/jcm11040968 |
Ejemplares similares
-
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Mantovani, Alessandro, et al.
Publicado: (2022) -
Coronavirus disease 2019 (COVID-19): we don’t leave women alone
por: Mantovani, Alessandro, et al.
Publicado: (2020) -
Platelets in Non-alcoholic Fatty Liver Disease
por: Dalbeni, Andrea, et al.
Publicado: (2022) -
MON-036 Lead Exposure Is Related to Macro- and Microvascular Diabetic Complications
por: Wang, Ningjian, et al.
Publicado: (2019) -
MAFLD and CKD: An Updated Narrative Review
por: Mantovani, Alessandro, et al.
Publicado: (2022)